Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. - Wikidata - wikimedia - TriplyDB

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

http://www.wikidata.org/entity/Q36154796

about

Multiple Sites Ultrasonography of Peripheral Nerves in Differentiating Charcot-Marie-Tooth Type 1A from Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.A New Classification System for IgG4 Autoantibodies.Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy.Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis

P2860

Q29994832-80B40F03-A3CB-448D-8ACB-75EDCDEB19FB Q38748481-6B5AACDB-9B09-4EA7-89D7-5928279DEFD8 Q39434973-57597B0F-FB7F-4328-8574-4C9B5FA2C80F Q43533051-03C1C4AF-1B92-425D-BA34-2E65D7DE1A6B Q47610103-D3FEE076-804C-4179-9B50-6365BD63C126 Q47611455-4AB8C757-18BE-4079-8824-6B6D2A3964AD Q48110568-8C09754B-42D2-43C7-A4DE-1F22AE2123D5 Q50327901-6AE5E60B-3CD5-44FC-952F-201C94767831 Q55010646-6789B7F0-E9F0-4A70-B668-0CDD707DFEBB Q55021064-57C0BC50-BDA6-41D6-BC36-0F0E09B01E96 Q57300562-E4FCD3A2-C49D-4085-8B2E-BE794E86249A Q58702983-505F7E35-675C-4D71-9A69-AD9CBEDBB869

P2860

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

http://www.wikidata.org/entity/Q36154796

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@ast

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@en

type

label

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@ast

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@en

prefLabel

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@ast

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@en

P1433

Q36154796-2DFEE657-3302-4317-9100-C4DF05F2FE0C

P1476

Q36154796-5783735F-F6F8-48E6-8180-C06318EBCD31

P2093

Q36154796-10CB9FF6-9D64-4966-B6EB-E91893E8EF9D

Q36154796-136D7A26-BA7A-4561-95B4-F287C4B46FF1

Q36154796-3AEC376B-F3FB-4C92-A417-736EFCADE9F4

Q36154796-43414E5B-F91D-4481-850B-D80B3AA2DB7B

Q36154796-594E02C5-E3F3-403F-A223-9FA2239A12F9

Q36154796-5B8176F2-732E-4511-9260-B3EA7BBEE243

Q36154796-83C45285-4713-454A-B7F6-CE76C776E448

Q36154796-8AABEF25-06A3-413B-9139-016143AB54A2

Q36154796-94020566-DED6-4E53-A372-55952B3C3F27

Q36154796-A34BDA9D-9E9D-493E-BFFB-D16808D744D8

P2860

Q36154796-177DB6D3-65BB-4102-9EA7-7A2C1B7CAAB9

Q36154796-30339FA1-61DD-45BF-B761-DB318D7876B0

Q36154796-348C1327-89F9-41DA-8494-73E5861F9BFF

Q36154796-44DA412C-CFD1-4199-8015-343383C01394

Q36154796-44EC2730-5498-494F-B857-DA431568202B

Q36154796-4D8420AA-65FC-426F-B34D-21AC8A9B24D2

Q36154796-52C422BC-A05A-44DA-ADB7-A9CB93AAE86B

Q36154796-60D563CE-CE13-4489-AD6E-104BCA2C4DD1

Q36154796-6323E82D-C14C-47E5-B261-11D1C57CF6AE

Q36154796-72F72BD6-FD4D-4F12-9909-C2027447812C

P304

Q36154796-EEB27A81-884F-49A1-847D-37C064DF07A0

P31

Q36154796-E65737B7-5CEF-4E05-993D-FE1DA8A69530

P356

Q36154796-8256F6FC-3E77-4E31-B844-D3664CE4339A

P433

Q36154796-1F9FE39A-DB12-4216-9648-8AE5D1184384

P478

Q36154796-5F1F76D3-4789-462B-9D70-5B999A418F90

P50

Q36154796-E74DF478-D8EB-44CF-A830-F41511B519BF

P577

Q36154796-4F634493-7FCA-4DEB-B97D-B4CBF40C6B9F

P5875

Q36154796-5C3818AE-17AD-43CD-BCAE-B704F40A50DB

P698

Q36154796-D61E1C84-3A66-40FA-93F3-07B767911FC6

P932

Q36154796-10A8AC97-2F07-4655-87D1-4AFBBA92A244

P356

P1433

Annals of clinical and translational neurology

P1476

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.

@en

P2093

Akio Hiwatashi

http://www.w3.org/2001/XMLSchema#string

Dai Matsuse

http://www.w3.org/2001/XMLSchema#string

Fumiaki Tanaka

http://www.w3.org/2001/XMLSchema#string

Hidekazu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hidenori Ogata

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Murai

http://www.w3.org/2001/XMLSchema#string

Hitaru Kishida

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Kira

http://www.w3.org/2001/XMLSchema#string

Koji Ikezoe

http://www.w3.org/2001/XMLSchema#string

Motoi Kuwahara

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of current diagnostic criteria for Guillain-Barré syndrome

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Neurofascins are required to establish axonal domains for saltatory conduction

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.

Organizing principles of the axoglial apparatus.

POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

Anti-GQ1b IgG antibody syndrome: clinical and immunological range.

P304

960-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.248

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Susumu Kusunoki

P577

2015-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281672314

http://www.w3.org/2001/XMLSchema#string

P698

26478896

http://www.w3.org/2001/XMLSchema#string

P932

4603379

http://www.w3.org/2001/XMLSchema#string